glp-1 weight loss study Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Obesity Clinical Trials | Expert

For some, seeing one of the most dominant athletes of all time promote weight loss drugs felt jarring, especially given her long-standing role as a symbol of strength, power, and body confidence

The doublespeak triggered some backlashnot only because the company is, in fact, capitalizing on the $15 billion weight-loss drug market, but because the company also didnt explicitly mention in the voiceover that it sells the compounded version of these medications (made by combining, mixing, or altering ingredients), which arent approved by the FDA

To get the best results, you should consider what else is in your supplement stack

Such compounds are further broken down into water soluble compounds which are eliminated in the urine or bile

Mikami, Y